{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:31:24Z","timestamp":1790404284825,"version":"4.1.0"},"reference-count":27,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"DOI":"10.1210\/jc.2008-0743","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T04:18:27Z","timestamp":1216181907000},"page":"3827-3832","source":"Crossref","is-referenced-by-count":84,"title":["Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency"],"prefix":"10.1210","volume":"93","author":[{"given":"Gareth G.","family":"Lavery","sequence":"first","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Walker","sequence":"additional","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tiganescu","sequence":"additional","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon P.","family":"Ride","sequence":"additional","affiliation":[{"name":"School of Biosciences (J.P.R.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric H. L.","family":"Shackleton","sequence":"additional","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W.","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M. C.","family":"Connell","sequence":"additional","affiliation":[{"name":"Medical Research Council Blood Pressure Group (J.M.C.C.), University of Glasgow, G12 8TA Glasgow, Scotland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ray","sequence":"additional","affiliation":[{"name":"Endocrine Sciences Research Group (D.W.R.), University of Manchester, Manchester M13 9PT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Biason-Lauber","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital (A.B.-L.), CH-8032 Zu\u0308rich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa M.","family":"Malunowicz","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnostics (E.M.M.), The Children\u2019s Memorial Health Institute, 04-736 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Division of Medical Sciences (G.G.L., E.A.W., A.T., C.H.L.S., J.W.T., W.A., P.M.S.), University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114024612100_R1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114024612100_R2","first-page":"260","article-title":"Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolism.","volume":"53","author":"Biason-Lauber","year":"2000","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041114024612100_R3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11\u03b2-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.","volume":"34","author":"Draper","year":"2003","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041114024612100_R4","first-page":"3570","article-title":"Apparent cortisone reductase deficiency: a functional defect in 11\u03b2-hydroxysteroid dehydrogenase type 1.","volume":"84","author":"Jamieson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R5","first-page":"205","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 deficiency (\u2018apparent cortisone reductase deficiency\u2019) in a 6-year-old boy.","volume":"59","author":"Malunowicz","year":"2003","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041114024612100_R6","first-page":"687","article-title":"Defects in the HSD11 gene encoding 11\u03b2-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.","volume":"77","author":"Nikkila","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R7","first-page":"3855","article-title":"Apparent cortisone reductase deficiency: a unique form of hypercortisolism.","volume":"81","author":"Phillipov","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R8","first-page":"265","article-title":"Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism","author":"White","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t2019041114024612100_R9","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M512635200","article-title":"Hexose-6-phosphate dehydrogenase knock-out mice lack 11\u03b2-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation.","volume":"281","author":"Lavery","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114024612100_R10","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114024612100_R11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2265.2006.02547.x","article-title":"Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.","volume":"65","author":"Draper","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114024612100_R12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2006-1349","article-title":"Lack of association of the 11\u03b2-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia.","volume":"92","author":"Smit","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R13","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1210\/jc.2005-0942","article-title":"Genotypes at 11\u03b2-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.","volume":"90","author":"White","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-G","article-title":"Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research.","volume":"45","author":"Shackleton","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t2019041114024612100_R15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry.","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/jcem-38-2-169","article-title":"Intercomparison of four methods for measuring cortisol production.","volume":"38","author":"Zumoff","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.febslet.2004.06.065","article-title":"Hexose-6-phosphate dehydrogenase determines the reaction direction of 11\u03b2-hydroxysteroid dehydrogenase type 1 as an oxoreductase.","volume":"571","author":"Atanasov","year":"2004","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t2019041114024612100_R18","doi-asserted-by":"crossref","first-page":"27017","DOI":"10.1074\/jbc.M404159200","article-title":"Cooperativity between 11\u03b2-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum.","volume":"279","author":"Banhegyi","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114024612100_R19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1677\/jme.1.01718","article-title":"Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11\u03b2-hydroxysteroid dehydrogenase type 1.","volume":"34","author":"Bujalska","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041114024612100_R20","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1210\/endo.140.7.6868","article-title":"Differentiation of adipose stromal cells: the roles of glucocorticoids and 11\u03b2-hydroxysteroid dehydrogenase.","volume":"140","author":"Bujalska","year":"1999","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114024612100_R21","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.1074\/jbc.M710067200","article-title":"Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy.","volume":"283","author":"Lavery","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114024612100_R22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114024612100_R23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome.","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114024612100_R24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.beem.2006.02.005","article-title":"Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.","volume":"20","author":"Goodarzi","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114024612100_R25","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/en.2003-0344","article-title":"Selective inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.","volume":"144","author":"Alberts","year":"2003","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114024612100_R26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11\u03b2-hydroxysteroid dehydrogenase type 1-deficient mice.","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114024612100_R27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0023","article-title":"Mechanisms of disease: Selective inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.","volume":"1","author":"Tomlinson","year":"2005","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/10\/3827\/9053907\/jcem3827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T17:39:17Z","timestamp":1557682757000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/10\/3827\/2627320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-0743","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}